RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 96 filers reported holding RAPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $692,389 | -16.9% | 41,660 | -6.5% | 0.00% | 0.0% |
| Q2 2023 | $833,197 | -59.1% | 44,556 | -59.9% | 0.00% | 0.0% |
| Q1 2023 | $2,038,979 | +19.7% | 111,116 | +29.2% | 0.00% | 0.0% |
| Q4 2022 | $1,702,939 | +8.0% | 86,007 | +31.2% | 0.00% | 0.0% |
| Q3 2022 | $1,577,000 | -45.9% | 65,549 | -58.9% | 0.00% | -50.0% |
| Q2 2022 | $2,914,000 | +807.8% | 159,672 | +994.3% | 0.00% | – |
| Q1 2022 | $321,000 | -87.3% | 14,591 | -78.8% | 0.00% | -100.0% |
| Q4 2021 | $2,524,000 | +1797.7% | 68,721 | +1498.9% | 0.00% | – |
| Q3 2021 | $133,000 | +54.7% | 4,298 | +58.4% | 0.00% | – |
| Q2 2021 | $86,000 | +186.7% | 2,714 | +99.1% | 0.00% | – |
| Q1 2021 | $30,000 | -56.5% | 1,363 | -61.1% | 0.00% | – |
| Q4 2020 | $69,000 | +305.9% | 3,508 | +565.7% | 0.00% | – |
| Q3 2020 | $17,000 | -60.5% | 527 | -64.5% | 0.00% | – |
| Q2 2020 | $43,000 | +377.8% | 1,484 | +255.9% | 0.00% | – |
| Q1 2020 | $9,000 | +12.5% | 417 | +33.2% | 0.00% | – |
| Q4 2019 | $8,000 | – | 313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |